mutation predictions | marginal predictions | summary statistics | genome diff | command line log
|
breseq version 0.33.1 revision 8505477f25b3
mutation predictions | marginal predictions | summary statistics | genome diff | command line log |
| Predicted mutations | ||||||
|---|---|---|---|---|---|---|
| evidence | position | mutation | freq | annotation | gene | description |
| RA | 35,814 | Δ1 bp | 24.0% | intergenic (+45/+63) | rlmH → / ← tpn | hypothetical protein/IS431mec transposase |
| RA | 35,817 | A→T | 26.1% | intergenic (+48/+60) | rlmH → / ← tpn | hypothetical protein/IS431mec transposase |
| RA | 35,850 | C→T | 32.5% | intergenic (+81/+27) | rlmH → / ← tpn | hypothetical protein/IS431mec transposase |
| RA | 35,858 | T→A | 33.9% | intergenic (+89/+19) | rlmH → / ← tpn | hypothetical protein/IS431mec transposase |
| RA | 35,876 | C→T | 43.3% | intergenic (+107/+1) | rlmH → / ← tpn | hypothetical protein/IS431mec transposase |
| RA | 35,913 | C→G | 22.4% | S213S (TCG→TCC) | tpn ← | IS431mec transposase |
| RA | 35,940 | G→A | 24.4% | R204R (CGC→CGT) | tpn ← | IS431mec transposase |
| RA | 35,970 | T→C | 52.1% | E194E (GAA→GAG) | tpn ← | IS431mec transposase |
| RA | 35,997 | T→C | 25.2% | T185T (ACA→ACG) | tpn ← | IS431mec transposase |
| RA | 36,015 | C→T | 24.3% | R179R (AGG→AGA) | tpn ← | IS431mec transposase |
| RA | 36,087 | A→G | 63.1% | C155C (TGT→TGC) | tpn ← | IS431mec transposase |
| RA | 36,119 | C→T | 22.1% | V145I (GTA→ATA) | tpn ← | IS431mec transposase |
| RA | 36,124 | G→A | 61.7% | A143V (GCT→GTT) | tpn ← | IS431mec transposase |
| RA | 36,133 | A→G | 24.7% | V140A (GTA→GCA) | tpn ← | IS431mec transposase |
| RA | 36,161 | T→C | 24.1% | I131V (ATT→GTT) | tpn ← | IS431mec transposase |
| RA | 36,174 | T→C | 23.8% | K126K (AAA→AAG) | tpn ← | IS431mec transposase |
| RA | 36,269 | C→T | 54.4% | A95T (GCA→ACA) | tpn ← | IS431mec transposase |
| RA | 36,315 | G→A | 53.0% | Y79Y (TAC→TAT) | tpn ← | IS431mec transposase |
| RA | 36,378 | C→T | 85.0% | L58L (TTG→TTA) | tpn ← | IS431mec transposase |
| RA | 36,413 | C→T | 44.9% | V47I (GTC→ATC) | tpn ← | IS431mec transposase |
| RA | 36,444 | C→T | 36.9% | R36R (AGG→AGA) | tpn ← | IS431mec transposase |
| RA | 36,471 | A→G | 20.7% | S27S (AGT→AGC) | tpn ← | IS431mec transposase |
| RA | 36,479 | T→C | 17.9% | T25A (ACA→GCA) | tpn ← | IS431mec transposase |
| RA | 36,581 | C→T | 34.4% | intergenic (‑30/‑493) | tpn ← / → USA300HOU_0028 | IS431mec transposase/hypothetical protein |
| JC | 62,817 | +TCAATT | 94.2% | intergenic (+82/+229) | USA300HOU_0056 → / ← speG | hypothetical protein/diamine N‑acetyltransferase |
| RA | 76,180 | C→T | 18.2% | intergenic (+238/‑896) | USA300HOU_0072 → / → USA300HOU_0075 | universal stress protein/lysophospholipase |
| RA | 76,185 | G→A | 12.4% | intergenic (+243/‑891) | USA300HOU_0072 → / → USA300HOU_0075 | universal stress protein/lysophospholipase |
| RA | 76,265 | C→T | 21.3% | intergenic (+323/‑811) | USA300HOU_0072 → / → USA300HOU_0075 | universal stress protein/lysophospholipase |
| RA | 76,295 | T→C | 54.7% | intergenic (+353/‑781) | USA300HOU_0072 → / → USA300HOU_0075 | universal stress protein/lysophospholipase |
| RA | 76,322 | G→A | 52.1% | intergenic (+380/‑754) | USA300HOU_0072 → / → USA300HOU_0075 | universal stress protein/lysophospholipase |
| RA | 76,353 | G→A | 47.8% | intergenic (+411/‑723) | USA300HOU_0072 → / → USA300HOU_0075 | universal stress protein/lysophospholipase |
| RA | 89,761 | G→A | 10.8% | intergenic (‑805/+1940) | USA300HOU_0086 ← / ← USA300HOU_0089 | hypothetical protein/hypothetical protein |
| RA | 110,651 | C→T | 8.6% | D170D (GAC→GAT) | USA300HOU_0109 → | staphylococcal tandem lipoprotein |
| RA | 110,660 | T→A | 15.2% | I173I (ATT→ATA) | USA300HOU_0109 → | staphylococcal tandem lipoprotein |
| RA | 111,512 | A→G | 25.6% | S194S (TCA→TCG) | USA300HOU_0110 → | possible staphylococcal tandem lipoprotein |
| RA | 111,516 | C→A | 25.8% | Q196K (CAA→AAA) | USA300HOU_0110 → | possible staphylococcal tandem lipoprotein |
| RA | 119,473 | A→G | 9.8% | H380H (CAT→CAC) | yjbB ← | possible PnaS family phosphate:sodium (Na+) symporter |
| RA | 119,491 | T→C | 9.6% | K374K (AAA→AAG) | yjbB ← | possible PnaS family phosphate:sodium (Na+) symporter |
| RA | 124,550 | G→A | 10.9% | D229N (GAT→AAT) | norG → | possible bifunctional GntR family transcriptional regulator/aminotransferase |
| RA | 147,927 | G→T | 9.4% | intergenic (+85/‑59) | budC → / → USA300HOU_0139 | short chain dehydrogenase/hypothetical protein |
| RA | 147,963 | G→A | 7.9% | intergenic (+121/‑23) | budC → / → USA300HOU_0139 | short chain dehydrogenase/hypothetical protein |
| RA | 267,872 | T→C | 13.0% | R525R (CGT→CGC) | USA300HOU_0238 → | staphylocoagulase |
| RA | 284,902 | T→C | 13.4% | A241A (GCA→GCG) | ptsG ← | PTS family glucose/glucoside (glc) porter component IIABC |
| RA | 336,153 | A→G | 9.1% | G97G (GGA→GGG) | essC → | virulence protein EssC |
| RA | 400,404 | A→G | 9.7% | S13P (TCA→CCA) | tatC ← | Tat family twin arginine targeting transporter TatC |
| RA | 401,596 | A→G | 10.3% | K47K (AAA→AAG) | USA300HOU_0370 → | possible transcriptional regulator |
| RA | 401,629 | T→G | 8.8% | T58T (ACT→ACG) | USA300HOU_0370 → | possible transcriptional regulator |
| RA | 473,673 | G→A | 14.5% | K104K (AAG→AAA) | USA300HOU_0449 → | hypothetical protein |
| RA | 487,745 | T→C | 7.7% | intergenic (+3123/‑2655) | USA300HOU_0463 → / → metQ | hypothetical protein/ABC superfamily ATP binding cassette transporter, binding protein |
| RA | 487,811 | A→G | 6.3% | intergenic (+3189/‑2589) | USA300HOU_0463 → / → metQ | hypothetical protein/ABC superfamily ATP binding cassette transporter, binding protein |
| RA | 512,643 | A→G | 51.8% | intergenic (+711/‑150) | recR → / → rrs1 | recombination protein RecR/16S ribosomal RNA |
| RA | 543,160 | C→T | 7.5% | T150I (ACA→ATA) | mazG → | possible tetrapyrrole methyltransferase |
| RA | 660,088 | A→T | 8.9% | intergenic (+349/‑18) | USA300HOU_0600 → / → USA300HOU_0601 | hypothetical protein/hypothetical protein |
| RA | 689,983 | G→T | 8.9% | S30Y (TCT→TAT) | USA300HOU_0631 ← | hypothetical membrane protein |
| RA | 725,201 | A→C | 9.1% | I30L (ATT→CTT) | dhaK → | glycerone kinase |
| RA | 730,535 | T→C | 11.0% | intergenic (+142/‑187) | lipA → / → USA300HOU_0677 | possible S9C family peptidase/hypothetical protein |
| RA | 770,855 | A→G | 13.5% | intergenic (+41/‑212) | ebsC → / → fruR | possible transcriptional regulator/DeoR family transcriptional regulator |
| RA | 820,942 | G→A | 10.5% | intergenic (+19/+170) | glxK → / ← pepT | glycerate kinase/M20 family peptidase T |
| RA | 853,592 | C→T | 8.7% | E183K (GAA→AAA) | USA300HOU_0798 ← | nucleoside‑diphosphate sugar epimerase |
| RA | 942,216 | T→A | 9.7% | intergenic (‑187/+62) | USA300HOU_0905 ← / ← mnhG2 | hypothetical protein/CPA3 family monovalent cation:proton (H+) antiporter‑3 subunit G |
| RA | 942,221 | T→A | 10.0% | intergenic (‑192/+57) | USA300HOU_0905 ← / ← mnhG2 | hypothetical protein/CPA3 family monovalent cation:proton (H+) antiporter‑3 subunit G |
| RA | 987,475 | A→T | 11.6% | intergenic (+48/+7) | fabH2 → / ← USA300HOU_0943 | 3‑oxoacyl‑[acyl‑carrier‑protein] synthase/hypothetical membrane protein |
| RA | 1,034,893 | G→A | 12.2% | intergenic (‑1310/‑6396) | USA300HOU_0983 ← / → USA300HOU_0984 | competence protein/glycosyltransferase |
| RA | 1,034,902 | G→T | 12.6% | intergenic (‑1319/‑6387) | USA300HOU_0983 ← / → USA300HOU_0984 | competence protein/glycosyltransferase |
| RA | 1,095,871 | C→T | 8.1% | V341V (GTC→GTT) | cydA → | cytochrome d ubiquinol oxidase subunit I |
| RA | 1,127,745 | A→T | 17.2% | intergenic (‑201/‑80) | ctaA ← / → ctaB | cytochrome oxidase assembly protein/protoheme IX farnesyltransferase |
| RA | 1,191,016 | C→G | 12.5% | T241T (ACC→ACG) | mraY → | phospho‑N‑acetylmuramoyl‑pentapeptide‑ transferase |
| RA | 1,225,067 | C→A | 11.2% | R690S (CGT→AGT) | priA → | primosomal protein N prime |
| RA | 1,228,195 | A→G | 8.2% | Q61Q (CAA→CAG) | fmt2 → | methionyl‑tRNA formyltransferase |
| RA | 1,250,361 | C→T | 13.9% | A44V (GCA→GTA) | ftsY → | Sec family Type I general secretory pathway protein signal recognition particle protein FtsY |
| RA | 1,416,458 | A→T | 100% | I216N (ATT→AAT) | oppD ← | oligopeptide ABC superfamily ATP binding cassette transporter, ABC protein |
| RA | 1,429,428 | T→A | 10.0% | V380E (GTA→GAA) | ykpA → | ABC superfamily ATP binding cassette transporter binding protein |
| RA | 1,446,968 | A→T | 9.5% | N89K (AAT→AAA) | yojO ← | hypothetical protein |
| RA | 1,451,876 | T→C | 12.5% | A682A (GCA→GCG) | sucA ← | oxoglutarate dehydrogenase (succinyl‑transferring) E1 |
| RA | 1,460,199 | T→A | 15.2% | intergenic (‑231/+169) | USA300HOU_1356 ← / ← ctpA | possible acetyltransferase/S41A family carboxy‑terminal peptidase |
| RA | 1,513,930 | A→T | 100% | L413F (TTA→TTT) | USA300HOU_1379 → | hypothetical membrane protein |
| RA | 1,646,189 | G→C | 100% | A155G (GCA→GGA) | pepP ← | M24B family Xaa‑Pro dipeptidase |
| RA | 1,680,195 | C→T | 11.1% | L96L (TTG→TTA) | cdd ← | cytidine deaminase |
| RA | 1,880,641 | C→A | 11.5% | A1526A (GCG→GCT) | fmtB1 ← | cell surface anchored protein |
| RA | 1,880,650 | A→T | 12.7% | I1523I (ATT→ATA) | fmtB1 ← | cell surface anchored protein |
| RA | 1,880,656 | G→T | 12.2% | R1521R (CGC→CGA) ‡ | fmtB1 ← | cell surface anchored protein |
| RA | 1,880,657 | C→T | 10.8% | R1521H (CGC→CAC) ‡ | fmtB1 ← | cell surface anchored protein |
| RA | 1,880,668 | T→C | 10.4% | E1517E (GAA→GAG) | fmtB1 ← | cell surface anchored protein |
| RA | 1,880,683 | A→T | 10.1% | V1512V (GTT→GTA) | fmtB1 ← | cell surface anchored protein |
| RA | 1,880,716 | G→T | 9.9% | D1501E (GAC→GAA) | fmtB1 ← | cell surface anchored protein |
| RA | 1,922,908 | G→T | 12.5% | intergenic (‑100/+59) | menE ← / ← USA300HOU_1785 | o‑succinylbenzoic acid‑‑CoA ligase/hypothetical protein |
| RA | 1,929,796 | T→C | 30.9% | intergenic (‑879/‑289) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
| RA | 1,929,797 | G→A | 30.5% | intergenic (‑880/‑288) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
| RA | 1,929,799 | C→A | 29.6% | intergenic (‑882/‑286) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
| RA | 1,929,804 | A→G | 31.7% | intergenic (‑887/‑281) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
| RA | 1,929,812 | G→A | 38.7% | intergenic (‑895/‑273) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
| RA | 1,929,843 | Δ1 bp | 47.4% | intergenic (‑926/‑242) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
| RA | 1,929,848 | C→A | 46.5% | intergenic (‑931/‑237) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
| RA | 1,929,861 | T→C | 47.3% | intergenic (‑944/‑224) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
| RA | 1,929,862:1 | +T | 35.5% | intergenic (‑945/‑223) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
| RA | 1,929,864 | A→T | 11.5% | intergenic (‑947/‑221) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
| RA | 1,929,865 | A→C | 35.7% | intergenic (‑948/‑220) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
| RA | 1,929,866 | G→T | 45.7% | intergenic (‑949/‑219) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
| RA | 1,929,867 | G→T | 46.4% | intergenic (‑950/‑218) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
| RA | 1,929,870 | A→C | 46.6% | intergenic (‑953/‑215) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
| RA | 1,929,872 | G→A | 46.7% | intergenic (‑955/‑213) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
| RA | 1,929,873 | C→A | 46.5% | intergenic (‑956/‑212) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
| RA | 1,929,875 | T→C | 48.0% | intergenic (‑958/‑210) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
| RA | 1,929,917 | C→T | 39.7% | intergenic (‑1000/‑168) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
| RA | 1,929,918 | A→G | 38.7% | intergenic (‑1001/‑167) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
| RA | 1,929,925 | T→A | 31.8% | intergenic (‑1008/‑160) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
| RA | 1,929,928 | T→A | 32.0% | intergenic (‑1011/‑157) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
| RA | 1,929,930 | T→A | 33.1% | intergenic (‑1013/‑155) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
| RA | 1,929,941 | A→T | 27.8% | intergenic (‑1024/‑144) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
| RA | 1,929,946 | G→A | 25.0% | intergenic (‑1029/‑139) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
| RA | 1,930,186 | A→G | 12.1% | *34* (TAA→TAG) | USA300HOU_1796 → | hypothetical protein |
| RA | 2,010,363 | C→T | 100% | C146Y (TGT→TAT) | ygaD ← | ABC superfamily ATP binding cassette transporter, membrane protein |
| RA | 2,065,589 | T→C | 8.2% | K129E (AAG→GAG) | USA300HOU_1919 ← | hypothetical protein |
| RA | 2,070,854 | T→C | 7.7% | intergenic (‑20/‑250) | ykgB ← / → ykgB | hypothetical protein/hypothetical protein |
| RA | 2,102,773 | A→G | 11.8% | intergenic (‑233/+83) | USA300HOU_1961 ← / ← USA300HOU_1962 | hypothetical bacteriophage protein/hypothetical bacteriophage protein |
| RA | 2,102,781 | T→C | 9.8% | intergenic (‑241/+75) | USA300HOU_1961 ← / ← USA300HOU_1962 | hypothetical bacteriophage protein/hypothetical bacteriophage protein |
| RA | 2,102,791 | T→A | 10.3% | intergenic (‑251/+65) | USA300HOU_1961 ← / ← USA300HOU_1962 | hypothetical bacteriophage protein/hypothetical bacteriophage protein |
| RA | 2,102,802 | A→T | 10.0% | intergenic (‑262/+54) | USA300HOU_1961 ← / ← USA300HOU_1962 | hypothetical bacteriophage protein/hypothetical bacteriophage protein |
| RA | 2,102,803 | A→G | 10.0% | intergenic (‑263/+53) | USA300HOU_1961 ← / ← USA300HOU_1962 | hypothetical bacteriophage protein/hypothetical bacteriophage protein |
| RA | 2,119,382 | T→G | 7.4% | A288A (GCA→GCC) | USA300HOU_1992 ← | hypothetical protein |
| RA | 2,119,388 | G→A | 7.4% | N286N (AAC→AAT) | USA300HOU_1992 ← | hypothetical protein |
| RA | 2,119,394 | G→A | 7.4% | D284D (GAC→GAT) ‡ | USA300HOU_1992 ← | hypothetical protein |
| RA | 2,119,395 | T→G | 7.6% | D284A (GAC→GCC) ‡ | USA300HOU_1992 ← | hypothetical protein |
| RA | 2,119,406 | T→C | 7.3% | K280K (AAA→AAG) | USA300HOU_1992 ← | hypothetical protein |
| RA | 2,119,442 | T→C | 7.9% | L268L (TTA→TTG) | USA300HOU_1992 ← | hypothetical protein |
| RA | 2,119,457 | C→T | 7.1% | K263K (AAG→AAA) ‡ | USA300HOU_1992 ← | hypothetical protein |
| RA | 2,119,458 | T→G | 8.7% | K263T (AAG→ACG) ‡ | USA300HOU_1992 ← | hypothetical protein |
| RA | 2,119,459 | T→C | 9.2% | K263E (AAG→GAG) ‡ | USA300HOU_1992 ← | hypothetical protein |
| RA | 2,146,840 | A→T | 10.6% | intergenic (‑51/+369) | USA300HOU_2030 ← / ← hld | hypothetical protein/delta‑hemolysin |
| RA | 2,182,778 | A→G | 12.2% | N12N (AAT→AAC) | sprL ← | hypothetical protein |
| RA | 2,185,073 | G→T | 9.3% | intergenic (‑117/+317) | yhgF ← / ← fliA | S1 domain RNA‑binding protein/DNA‑directed RNA polymerase sigma subunit FliA |
| RA | 2,203,709 | T→C | 12.9% | K442K (AAA→AAG) | murF ← | UDP‑N‑acetylmuramoyl‑tripeptide‑‑D‑alanyl‑D‑ alanine ligase |
| RA | 2,279,545 | A→T | 9.2% | intergenic (+1213/+6819) | mtlD → / ← glmM | mannitol‑1‑phosphate 5‑dehydrogenase/phosphoglucosamine mutase |
| RA | 2,279,705 | G→A | 100% | intergenic (+1373/+6659) | mtlD → / ← glmM | mannitol‑1‑phosphate 5‑dehydrogenase/phosphoglucosamine mutase |
| RA | 2,301,747 | T→C | 9.5% | S442S (TCA→TCG) | USA300HOU_2160 ← | MFS family major facilitator transporter |
| RA | 2,340,488 | T→A | 8.2% | G751G (GGT→GGA) | hysA → | hyaluronate lyase |
| RA | 2,343,016 | A→G | 10.5% | T40A (ACT→GCT) | USA300HOU_2200 → | hypothetical protein |
| RA | 2,385,610 | A→C | 8.6% | intergenic (‑547/+85) | fmhB ← / ← USA300HOU_2245 | peptidoglycan pentaglycine interpeptide biosynthesis protein FmhB/hypothetical protein |
| RA | 2,427,156 | T→G | 9.9% | R314R (CGA→CGC) | USA300HOU_2291 ← | formate dehydrogenase alpha subunit |
| RA | 2,431,197 | A→G | 11.4% | S79S (TCA→TCG) | USA300HOU_2294 → | transcriptional regulator |
| RA | 2,492,250 | T→C | 7.8% | G266G (GGT→GGC) | yhfP → | possible zinc (Zn2+) dependent dehydrogenase |
| RA | 2,532,298 | A→T | 100% | T15T (ACA→ACT) | murN → | FemAB family peptidoglycan biosynthesis protein |
| RA | 2,554,822 | C→T | 7.7% | A70T (GCT→ACT) | USA300HOU_2413 ← | ABC superfamily ATP binding cassette transporter, ABC/membrane protein |
| RA | 2,559,065 | C→T | 10.8% | A157A (GCC→GCT) | bcr → | MFS family major facilitator transporter, bicyclomycin:cation symporter |
| RA | 2,559,840 | T→G | 10.5% | intergenic (+34/+89) | bcr → / ← USA300HOU_2421 | MFS family major facilitator transporter, bicyclomycin:cation symporter/hypothetical protein |
| RA | 2,595,720 | C→T | 11.1% | E57E (GAG→GAA) | celM ← | oligopeptide ABC superfamily ATP binding cassette transporter, membrane protein |
| RA | 2,615,390 | A→G | 7.7% | S815S (AGT→AGC) | USA300HOU_2480 ← | helicase |
| RA | 2,639,869 | A→G | 6.8% | L94L (TTA→CTA) | gntR ← | gluconate operon transcriptional repressor |
| RA | 2,642,644 | T→A | 10.6% | intergenic (‑2/+65) | ydaT ← / ← USA300HOU_2498 | hypothetical protein/hypothetical membrane protein |
| RA | 2,658,664 | A→T | 7.6% | A208A (GCT→GCA) | yfkO ← | FMN reductase |
| RA | 2,691,098 | A→T | 10.3% | S513S (TCT→TCA) | USA300HOU_2546 ← | RND superfamily resistance‑nodulation‑cell division:proton (H+) antiporter |
| RA | 2,704,800 | A→G | 7.0% | F348L (TTT→CTT) | crtQ ← | glycosyltransferase |
| RA | 2,723,625 | T→G | 12.2% | I190I (ATA→ATC) | ynzC ← | FeoB family ferrous iron (Fe2+) uptake protein |
| RA | 2,833,850 | A→T | 8.4% | L179L (CTT→CTA) | hisIE ← | bifunctional phosphoribosyl‑ATP pyrophosphatase/phosphoribosyl‑AMP cyclohydrolase |
| Unassigned new junction evidence | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| seq id | position | reads (cov) | reads (cov) | score | skew | freq | annotation | gene | product | ||
| * | ? | CP000730 | 9070 = | 47 (1.270) | 3 (0.080) | 3/250 | NT | 6.6% | coding (2039/2664 nt) | gyrA | DNA topoisomerase (ATP‑hydrolyzing) subunit A |
| ? | CP000730 | 9088 = | 40 (1.120) | coding (2057/2664 nt) | gyrA | DNA topoisomerase (ATP‑hydrolyzing) subunit A | |||||
| * | ? | CP000730 | 17741 = | 40 (1.080) | 4 (0.120) | 3/240 | NT | 9.5% | coding (350/939 nt) | USA300HOU_0013 | possible membrane protein |
| ? | CP000730 | 17834 = | 39 (1.130) | coding (443/939 nt) | USA300HOU_0013 | possible membrane protein | |||||
| * | ? | CP000730 | 38900 = | 35 (0.950) | 3 (0.090) | 3/244 | NT | 8.6% | coding (248/429 nt) | maoC | possible acyl dehydratase MaoC |
| ? | CP000730 | 38952 = | 31 (0.890) | coding (300/429 nt) | maoC | possible acyl dehydratase MaoC | |||||
| * | ? | CP000730 | 99262 = | 41 (1.110) | 2 (0.060) | 4/230 | NT | 5.4% | intergenic (+56/+16) | tfoX/USA300HOU_0099 | hypothetical protein/possible MFS family major facilitator transporter |
| ? | CP000730 | 99291 = | 34 (1.030) | coding (1208/1221 nt) | USA300HOU_0099 | possible MFS family major facilitator transporter | |||||
| * | ? | CP000730 | = 329211 | 31 (0.840) | 3 (0.090) | 3/238 | NT | 9.0% | intergenic (+79/+64) | USA300HOU_0295/USA300HOU_0296 | hypothetical membrane protein/hypothetical protein |
| ? | CP000730 | = 329244 | 32 (0.940) | intergenic (+112/+31) | USA300HOU_0295/USA300HOU_0296 | hypothetical membrane protein/hypothetical protein | |||||
| * | ? | CP000730 | 391559 = | 25 (0.680) | 3 (0.080) | 3/250 | NT | 11.1% | coding (564/927 nt) | USA300HOU_0358 | possible lactoylglutathione lyase |
| ? | CP000730 | 391580 = | 24 (0.670) | coding (585/927 nt) | USA300HOU_0358 | possible lactoylglutathione lyase | |||||
| * | ? | CP000730 | 418185 = | 46 (1.240) | 3 (0.090) | 3/242 | NT | 6.5% | intergenic (+38/+48) | ychF/USA300HOU_0385 | possible GTP‑binding protein/hypothetical protein |
| ? | CP000730 | 418213 = | 43 (1.240) | intergenic (+66/+20) | ychF/USA300HOU_0385 | possible GTP‑binding protein/hypothetical protein | |||||
| * | ? | CP000730 | 512620 = | 41 (1.110) | 30 (1.180) +40 bp |
29/178 | NT | 51.5% | intergenic (+688/‑173) | recR/rrs1 | recombination protein RecR/16S ribosomal RNA |
| ? | CP000730 | 1998278 = | NA (NA) | intergenic (‑6/+5) | USA300HOU_t0050/rrf4 | tRNA‑Val/5S ribosomal RNA | |||||
| * | ? | CP000730 | = 514610 | NA (NA) | 3 (0.090) | 3/244 | NT | 51.4% | intergenic (+278/‑96) | rrs1/rrl1 | 16S ribosomal RNA/23S ribosomal RNA |
| ? | CP000730 | = 558903 | 3 (0.080) | intergenic (+116/‑54) | USA300HOU_t0012/rrl2 | tRNA‑Ile/23S ribosomal RNA | |||||
| * | ? | CP000730 | = 517080 | NA (NA) | 3 (0.080) | 3/250 | NT | NA | noncoding (2375/2921 nt) | rrl1 | 23S ribosomal RNA |
| ? | CP000730 | = 517096 | NA (NA) | noncoding (2391/2921 nt) | rrl1 | 23S ribosomal RNA | |||||
| * | ? | CP000730 | 551684 = | 38 (1.030) | 4 (0.110) | 3/244 | NT | 11.1% | intergenic (+13/‑203) | cysK/sul | cysteine synthase/dihydropteroate synthase, subunit A |
| ? | CP000730 | 551723 = | 28 (0.800) | intergenic (+52/‑164) | cysK/sul | cysteine synthase/dihydropteroate synthase, subunit A | |||||
| * | ? | CP000730 | 802131 = | 47 (1.270) | 4 (0.120) | 4/236 | NT | 9.5% | intergenic (+372/+252) | USA300HOU_0748/dgkA1 | hypothetical protein/possible diacylglycerol kinase |
| ? | CP000730 | 802180 = | 33 (0.980) | intergenic (+421/+203) | USA300HOU_0748/dgkA1 | hypothetical protein/possible diacylglycerol kinase | |||||
| * | ? | CP000730 | = 1164938 | 33 (0.890) | 3 (0.090) | 3/238 | NT | 9.5% | intergenic (+2/‑160) | USA300HOU_1090/USA300HOU_1091 | hypothetical protein/hypothetical protein |
| ? | CP000730 | = 1164987 | 27 (0.790) | intergenic (+51/‑111) | USA300HOU_1090/USA300HOU_1091 | hypothetical protein/hypothetical protein | |||||
| * | ? | CP000730 | 1277483 = | 37 (1.000) | 4 (0.120) | 3/238 | NT | 11.7% | intergenic (+81/‑865) | pyrH/uppS | UMP kinase/di‑trans, poly‑cis‑decaprenylcistransferase |
| ? | CP000730 | 1277520 = | 26 (0.760) | intergenic (+118/‑828) | pyrH/uppS | UMP kinase/di‑trans, poly‑cis‑decaprenylcistransferase | |||||
| * | ? | CP000730 | = 1637435 | 31 (0.840) | 3 (0.080) | 3/250 | NT | 8.6% | coding (1119/1680 nt) | recN | DNA repair protein RecN |
| ? | CP000730 | = 1637444 | 34 (0.950) | coding (1110/1680 nt) | recN | DNA repair protein RecN | |||||
| * | ? | CP000730 | 2080720 = | 43 (1.160) | 3 (0.090) | 3/244 | NT | 6.8% | intergenic (‑188/+55) | USA300HOU_1938/USA300HOU_1939 | hypothetical protein/hypothetical protein |
| ? | CP000730 | 2080773 = | 41 (1.170) | intergenic (‑241/+2) | USA300HOU_1938/USA300HOU_1939 | hypothetical protein/hypothetical protein | |||||
| * | ? | CP000730 | = 2082378 | 46 (1.240) | 4 (0.120) | 4/236 | NT | 7.8% | intergenic (+19/+606) | USA300HOU_1940/mapW2 | aminotransferase/cell surface protein MapW2 |
| ? | CP000730 | = 2082394 | 52 (1.540) | intergenic (+35/+590) | USA300HOU_1940/mapW2 | aminotransferase/cell surface protein MapW2 | |||||
| * | ? | CP000730 | = 2142483 | 42 (1.140) | 3 (0.090) | 3/242 | NT | 7.0% | intergenic (‑36/‑139) | groES/USA300HOU_2026 | chaperone GroES/hypothetical membrane protein |
| ? | CP000730 | = 2142494 | 40 (1.150) | intergenic (‑47/‑128) | groES/USA300HOU_2026 | chaperone GroES/hypothetical membrane protein | |||||
| * | ? | CP000730 | = 2760340 | 40 (1.080) | 3 (0.090) | 3/236 | NT | 6.9% | coding (659/1371 nt) | citM | CitMHS family citrate‑magnesium (Mg2+):proton (H+) citrate‑calcium (Ca2+):proton (H+) symporter |
| ? | CP000730 | = 2760395 | 44 (1.300) | coding (604/1371 nt) | citM | CitMHS family citrate‑magnesium (Mg2+):proton (H+) citrate‑calcium (Ca2+):proton (H+) symporter | |||||
| * | ? | CP000730 | = 2772645 | 36 (0.970) | 4 (0.120) | 4/232 | NT | 10.5% | intergenic (+19/+41) | phoB/USA300HOU_2627 | alkaline phosphatase/hypothetical protein |
| ? | CP000730 | = 2772662 | 36 (1.080) | intergenic (+36/+24) | phoB/USA300HOU_2627 | alkaline phosphatase/hypothetical protein | |||||
| * | ? | CP000730 | = 2847743 | 34 (0.920) | 7 (0.210) | 4/230 | NT | 18.6% | intergenic (+52/+97) | USA300HOU_2689/cbiQ | hypothetical protein/possible gluconolactonase |
| ? | CP000730 | = 2847754 | 31 (0.940) | intergenic (+63/+86) | USA300HOU_2689/cbiQ | hypothetical protein/possible gluconolactonase | |||||